miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A-Reference-Cited by-同舟云学术

miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A

Published:2020-05 Issue:5 Volume:47 Page:3909-3918
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Gholampour Mohammad Ali,Asadi Marjan,Naderi Mehran,Azarkeivan Azita,Soleimani Masoud,Atashi Amir^ORCID

Funder

Tarbiat Modares University

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-020-05483-7.pdf

Reference39 articles.

1. Mettananda S, Gibbons RJ, Higgs DR (2015) α-Globin as a molecular target in the treatment of β-thalassemia. Blood J Am Soc Hematol 125(24):3694–3701

2. Dimou NL, Pantavou KG, Bagos PG (2017) Apolipoprotein E polymorphism and left ventricular failure in beta-thalassemia: a multivariate meta-analysis. Ann Hum Genet 81(5):213–223

3. Nienhuis AW, Nathan DG (2012) Pathophysiology and clinical manifestations of the β-thalassemias. Cold Spring Harb Perspect Med 2(12):a011726

4. Voskaridou E, Balassopoulou A, Boutou E, Komninaka V, Christoulas D, Dimopoulou M, Delaki EE, Loukopoulos D, Terpos E (2014) Pregnancy in beta-thalassemia intermedia: 20-year experience of a Greek thalassemia center. Eur J Haematol 93(6):492–499

5. Vichinsky E, Neumayr L, Trimble S, Giardina PJ, Cohen AR, Coates T, Boudreaux J, Neufeld EJ, Kenney K, Grant A (2014) Transfusion complications in thalassemia patients: a report from the C enters for D isease C ontrol and P revention (CME). Transfusion 54(4):972–981

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications;International Journal of Molecular Sciences;2024-04-12

2. Regulation of miR-17-3p on K562 cell proliferation and erythroid differentiation as well as γ-globin expression in patients with β-thalassemiar;2024-01-18

3. RNA therapeutics for the treatment of blood disorders;Progress in Molecular Biology and Translational Science;2024

4. Transcriptional Repressor BCL11A in Erythroid Cells;Advances in Experimental Medicine and Biology;2024

5. The clinical value of hsa-miR-190b-5p in peripheral blood of pediatric β-thalassemia and its regulation on BCL11A expression;PLOS ONE;2023-10-05